Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2018, Article ID 6384253, 7 pages
https://doi.org/10.1155/2018/6384253
Research Article

The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma

Department of Radiation Oncology, University of Kansas Cancer Center, Kansas University Medical Center, Kansas City, KS, USA

Correspondence should be addressed to Rohit Gunan Ganju; ude.cmuk@ujnagr

Received 28 September 2017; Revised 18 November 2017; Accepted 7 December 2017; Published 9 January 2018

Academic Editor: Akira Hara

Copyright © 2018 Rohit Gunan Ganju et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Graves, H. Hessamodini, G. Wong, and W. H. Lim, “Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities,” ImmunoTargets and Therapy, vol. 2, pp. 73–90, 2013. View at Google Scholar
  2. S. Siva, G. Kothari, A. Muacevic et al., “Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach,” Nature Reviews Urology, 2017. View at Google Scholar
  3. A. I. Chin, J. S. Lam, R. A. Figlin, and A. S. Belldegrun, “Surveillance strategies for renal cell carcinoma patients following nephrectomy,” Reviews in Urology, vol. 8, no. 1, pp. 1–7, 2006. View at Google Scholar
  4. C. Antczak, V. Q. Trinh, A. Sood et al., “The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis,” The Journal of Urology, vol. 191, no. 6, pp. 1678–1684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. SEER Cancer Stat Facts: Kidney and Renal Pelvis Cance, National Cancer Institute, Bethesda, MD.
  6. A. Lipton, A. Colombo-Berra, R. M. Bukowski et al., “Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid,” Clinical Cancer Research, vol. 10, no. 18, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lee, D. Hodgson, E. Chow et al., “A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma,” Cancer, vol. 104, no. 9, pp. 1894–1900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. DiBiase, R. K. Valicenti, D. Schultz, Y. Xie, L. G. Gomella, and B. W. Corn, “Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model,” The Journal of Urology, vol. 158, no. 3, part 1, pp. 746–749, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Onufrey and M. Mohiuddin, “Radiation therapy in the treatment of me tastatic renal cell carcinoma,” International Journal of Radiation Oncology • Biology • Physics, vol. 11, no. 11, pp. 2007–2009, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Amini, B. Altoos, M. T. Bourlon et al., “Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?” Practical Radiation Oncology, vol. 5, no. 6, pp. e589–e596, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Jhaveri, B. S. Teh, A. C. Paulino et al., “A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases,” Acta Oncologica, vol. 51, no. 5, pp. 584–588, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Svedman, P. Sandström, P. Pisa et al., “A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma,” Acta Oncologica, vol. 45, no. 7, pp. 870–875, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Ranck, D. W. Golden, K. S. Corbin et al., “Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma,” American Journal of Clinical Oncology, vol. 36, no. 6, pp. 589–595, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Stinauer, B. D. Kavanagh, T. E. Schefter et al., “Stereotactic body radiation therapy for melanoma and renal cell carcinoma: Impact of single fraction equivalent dose on local control,” Journal of Radiation Oncology, vol. 6, no. 1, article no. 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. B. S. Teh, C. Bloch, L. Doh et al., “The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT),” Biomedical Imaging and Intervention Journal, vol. 3, no. 1, article e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Zelefsky, C. Greco, R. Motzer et al., “Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma,” International Journal of Radiation Oncology • Biology • Physics, vol. 82, no. 5, pp. 1744–1748, 2012. View at Google Scholar
  17. D. Wilson, L. Hiller, L. Gray, M. Grainger, A. Stirling, and N. James, “The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma,” Clinical Oncology, vol. 15, no. 7, pp. 400–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. F. Harstell, C. B. Scott, D. W. Bruner et al., “Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases,” Journal of the National Cancer Institute, vol. 97, no. 11, pp. 798–804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Kothari, F. Foroudi, S. Gill, N. M. Corcoran, and S. Siva, “Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review,” Acta Oncologica, vol. 54, no. 2, pp. 148–157, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. “(P062) Comparison of Stereotactic Body Radiotherapy (SBRT) and Conventional External Beam Radiotherapy (EBRT) in Renal Cell Carcinoma (RCC),” Oncology (Williston Park), vol. 29, Supplement 1, no. 4, 2015.
  21. B. Altoos, A. Amini, M. Yacoub et al., “Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT),” Journal of Radiation Oncology, vol. 10, no. 1, article no. 218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. Ghia, E. L. Chang, A. J. Bishop et al., “Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: Secondary analysis of Phase I/II trials,” Journal of Neurosurgery: Spine, vol. 24, no. 5, pp. 829–836, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Miller, E. H. Balagamwala, L. Angelov et al., “Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma,” Journal of Neurosurgery: Spine, vol. 25, no. 6, pp. 766–774, 2016. View at Google Scholar
  24. J. Verma, E. Jonasch, P. K. Allen et al., “The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma,” American Journal of Clinical Oncology, vol. 36, no. 6, pp. 620–624, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. A. M.-L. Vakaet and T. Boterberg, “Pain control by ionizing radiation of bone metastasis,” The International Journal of Developmental Biology, vol. 48, no. 5-6, pp. 599–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Hamanishi, M. Mandai, N. Matsumura, K. Abiko, T. Baba, and I. Konishi, “PD-1/PD-L1 blockade in cancer treatment: perspectives and issues,” International Journal of Clinical Oncology, vol. 21, no. 3, pp. 462–473, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Demaria, E. B. Golden, and S. C. Formenti, “Role of local radiation therapy in cancer immunotherapy,” JAMA Oncology, vol. 1, no. 9, pp. 1325–1332, 2015. View at Publisher · View at Google Scholar · View at Scopus